title: Treatment trial of multicentric reticulohistiocytosis with a combination of predonisolone, methotrexate and alendronate.
authors.forename: Masataka
authors.initials: M
authors.lastname: Satoh
authors.forename: Noritaka
authors.initials: N
authors.lastname: Oyama
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Yamada
authors.forename: Koichiro
authors.initials: K
authors.lastname: Nakamura
authors.forename: Fumio
authors.initials: F
authors.lastname: Kaneko
mesh_terms: D000328:Adult; D019386:Alendronate / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015616:Histiocytosis, Non-Langerhans-Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D050071:Bone Density Conservation Agents; D011239:Prednisolone; D019386:Alendronate; D008727:Methotrexate